Valery Huot

Show Your Teeth with Impress – Europe’s #1 Orthodontic Clinics Impress operates over 110 clinics across 10 countries in Europe and the United States, transforming orthodontic care with cutting-edge clear aligner treatments. Our clear aligners are the preferred choice for both orthodontists and patients, offering a seamless way to achieve aligned, healthy teeth with ease, discretion, and comfort. We believe in empowering individuals to show their teeth and face the world with confidence and self-assurance. With over 15 years of expertise, our skilled orthodontists partner closely with the Impress medical team to develop personalized treatment plans that deliver visible results in as little as 6 months. In 2024, we strengthened our leadership in the orthodontics industry by acquiring DR SMILE, furthering our mission to make high-quality orthodontic care accessible to an even wider audience. With ambitious plans to expand through new clinic openings and market entries, we’re committed to reshaping the future of oral health care. Join over 200,000 satisfied patients worldwide who have transformed their smiles with Impress. Ready to take the first step? Show your teeth with Impress today!

We co-create with medical centers AI applications for radiology. Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects. We distribute the worlds top applications via a unified platform. Hundreds of start-ups have embarked on this adventure. They all want to produce AI to answer a specific clinical question. With our experience and our privileged relationship with the medical world, we support and integrate them on a dematerialized, secure, unique and simple platform. We are building together the future of radiology : more reliable, faster, for more lives saved. Incepto is this place at the crossroads of these paths: gathering solutions, market players and talents: Doctors, radiologists, researchers, data scientists, software developers, business developers, marketers and designers. Saving Time, Saving Lives, Together.

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

BIOSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France.

H4D est une société française spécialisée en télémédecine, créée en 2008 par le Dr. Franck Baudino. H4D offre un accès à un médecin à distance dispensé par la Consult StationⓇ. Ce cabinet médical connecté est une alternative pertinente lorsqu’une consultation traditionnelle n’est pas possible, permettant un service médical utile, étendu et professionnel. Cette offre s’adresse en priorité aux personnes confrontées à des difficultés d’accès aux soins : habitants de zones sous-médicalisées, salariés en entreprise, personnes âgées en hébergement collectif et étudiants.

BIOMODEX® is the leader in biorealistic haptic simulators and is based in Paris and Boston. Starting from standard patient-specific medical imaging, Biomodex has developed a unique and enhanced 3D printed solution for patient-specific rehearsal and physicians' advanced training, combining biomechanics and fluid dynamics and imaging properties. The Biomodex solution offers a tailored, end-to-end physician experience. The solution is fully integrated in both the imaging and procedural workflow, highly portable and easy to use. Image upload, ordering and quick delivery are facilitated through a web-based portal allowing customers to maintain their own portfolio of case cartridges. The solution is expected to result in reduced procedural and hospitalization costs and improved acute and chronic outcomes. Biomodex has successfully commercialized several products for neurovascular and structural heart applications and is fast expanding its product portfolio through the application of its core technologies. 

Were hiring worldwide! https://wandercraft.welcomekit.co/ At Wandercraft, we believe movement is freedom. Since 2012, our mission has been simple but bold: restore mobility where it’s been lost, and expand what’s possible with robotics that move like people do. We see robotics as the ultimate partners—machines that can do what humans cannot, or should not, do. That means giving back the ability to walk to someone with a spinal cord injury, or stepping in on a factory floor where work is too heavy, repetitive, or hazardous. We pioneered the world’s first self-balancing exoskeleton—technology that doesn’t rely on crutches or walkers, but lets people stand and walk freely. Today, our work goes beyond healthcare. From rehabilitation centers to factory floors, and soon into homes and communities, we’re shaping a future where humans and robots move forward together. Our technology, powered by physical AI and 30+ patents, is life-tested in the most demanding environments: real people, real steps, real work. Meet our devices: Atalante X – A self-balancing exoskeleton enabling hundreds of patients with mobility disabilities to take over 1 million steps per month in 100+ leading hospitals and research centers worldwide. It is designed to promote upright posture, cardiovascular health, neuroplasticity, and—most importantly—upright independence. Eve – The world’s first self-balancing exoskeleton for personal use. Designed for daily life, Eve enables individuals with severe mobility impairments to walk hands-free at home and outdoors. Currently in U.S. clinical trials, Eve is expected to launch in 2026. Calvin-40 – Our first industrial humanoid robot. Autonomous and voice-operated, Calvin-40 is built to take on physically demanding or hazardous tasks in non-ergonomic environments. Based on the same platform as our exoskeletons, Calvin is already hard at work with Renault Group and more.

Crocus Technology develops and supplies magnetic sensors based on its revolutionary and patented XtremeSense® TMR technology. Crocus’ magnetic sensors bring significant advantages to Industrial and Consumer Electronic applications requiring extremely high sensitivity, industry leading consistency of sensitivity over wide temperature range, low power and very low noise. The key product lines are Position Sensors (Switch, Linear and 2D positions), Current Sensors and customized modules. We are headquartered in Santa Clara, California, with a strong engineering site in Grenoble, France and sales and support offices worldwide. Visit our website for more details.

TES Electronic Solutions GmbH is an innovative technology and design services company offering intellectual properties (IP), embedded hard- and software for a vast range of customers in global markets, such as in industrial, automotive, consumer electronics, as well as in semiconductors. Key capabilities include embedded software, graphics, RF & antenna, radar, mixed-signal and digital ASIC and FPGA designs. #innovation #technology #embedded #ASIC #FPGA #graphics #semiconductor #embeddedsoftware #radar

JazzMutant had been the pioneering company in Multi-touch technology and was the first company ever to bring to the market a product featuring a Multi-touch display (2 years ahead of Apple's iphone). The company aimed at creating a new generation of touchscreen devices for electronic musicians and digital artists (VJs). Years before Tablets became mainstream devices, we designed and sold the Lemur, a portable touchscreen that enabled musicians to perform their digital music live, be it on stage or in the studio. The lemur was acclaimed by specialized press worldwide and had been endorsed by an impressive line up of legendary artists, including Daft Punk, Björk, Nine Inch Nails, Black Eyed Peas, Ritchie Hawtins, Justice, just to name a few of them.

Leader in humanoid robotics, SoftBank Robotics Europe (SBRE) is headquartered in Paris and regroups 400 employees. Creator of the robots NAO, Pepper and Romeo, used today in more than 70 countries worldwide, in various fields, such as research, education, retail, healthcare, tourism, hospitality or entertainment, SoftBank Robotics Europe is a subsidiary of SoftBank Robotics Holdings Corp. For more information: https://www.softbankrobotics.com/emea/en Facebook : Softbank Robotics Europe / Nao.therobot Twitter : @SBREurope / @PepperTheRobot / @NaoRobot Instagram : @SBREurope Youtube : Softbank Robotics Europe

Anevia is a leading OTT and IPTV software provider of innovative multiscreen solutions for the delivery of live TV, streaming video, time-shifted TV and video on demand services. The company offers a comprehensive portfolio of video compression, multiscreen IPTV head-ends, Cloud DVR and CDN solutions to enable viewers to enjoy a next-generation TV experience – anywhere, anytime and on any screen - including 4K UHD content. The solutions have been widely adopted by globally-renowned telecom and pay-TV operators, TV broadcasters and video service providers in hospitality, healthcare and corporate businesses. Founded in 2003, Anevia has a track record of being first to market with advanced video technologies. The company is a member and active contributor to several TV, media and hospitality industry associations. Headquartered in France, with regional offices in the USA, Dubai and Singapore, Anevia is listed on the Paris Euronext Growth market. Visit us at www.anevia.com Follow us @aneviaiptv

World-Class OLED Material and Technology Novaled GmbH, a leader in the organic light-emitting diode (OLED) field, specializes in high efficiency, long-lifetime OLED structures. With expertise in synthetic and analytical chemistry, we offer complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Our strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.

Depuis 1998 DoubleTrade propose aux entreprises privées et aux organismes publics des solutions simples et efficaces pour gérer l’ensemble du processus d’appel d’offres. Les solutions DoubleTrade s’adressent aux : Directions Commerciales ou Marketing souhaitant bénéficier d’un service de veille sur les appels d’offres, et détecter ainsi de nouveaux marchés tout en réduisant les coûts de prospection commerciale. Vous vous consacrez ainsi pleinement aux activités stratégiques de votre métier. L’utilisation des technologies web facilite par ailleurs la constante évolutivité des produits qui vous sont proposés de façon modulaire, en fonction de vos exigences. DoubleTrade est une société D’INTESCIA Group. INTESCIA a pour principal objectif de devenir la référence incontestable sur ses marchés spécifiques, en offrant à ses clients les outils et les services les plus performants et les plus adaptés à leurs exigences. Pour y parvenir, INTESCIA propose un catalogue de produits et de services qui font très largement appel aux nouveaux médias, qu’il s’agisse d’informations, de supports de décisions, de services marketing, d’Internet ou d’E-commerce.

eFront is the leading technology solution for alternative investment management, covering the needs of all alternative investment professionals end-to-end, from fundraising and portfolio construction to investment management and reporting. With more than 850 clients in 48 countries, eFront services clients worldwide across all major alternative asset classes. In 2019, eFront was acquired by BlackRock and integrated with Aladdin®, its investment technology, bringing together public and private asset classes to deliver the industry-leading multi-asset investment platform.

Show Your Teeth with Impress – Europe’s #1 Orthodontic Clinics Impress operates over 110 clinics across 10 countries in Europe and the United States, transforming orthodontic care with cutting-edge clear aligner treatments. Our clear aligners are the preferred choice for both orthodontists and patients, offering a seamless way to achieve aligned, healthy teeth with ease, discretion, and comfort. We believe in empowering individuals to show their teeth and face the world with confidence and self-assurance. With over 15 years of expertise, our skilled orthodontists partner closely with the Impress medical team to develop personalized treatment plans that deliver visible results in as little as 6 months. In 2024, we strengthened our leadership in the orthodontics industry by acquiring DR SMILE, furthering our mission to make high-quality orthodontic care accessible to an even wider audience. With ambitious plans to expand through new clinic openings and market entries, we’re committed to reshaping the future of oral health care. Join over 200,000 satisfied patients worldwide who have transformed their smiles with Impress. Ready to take the first step? Show your teeth with Impress today!

We co-create with medical centers AI applications for radiology. Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects. We distribute the worlds top applications via a unified platform. Hundreds of start-ups have embarked on this adventure. They all want to produce AI to answer a specific clinical question. With our experience and our privileged relationship with the medical world, we support and integrate them on a dematerialized, secure, unique and simple platform. We are building together the future of radiology : more reliable, faster, for more lives saved. Incepto is this place at the crossroads of these paths: gathering solutions, market players and talents: Doctors, radiologists, researchers, data scientists, software developers, business developers, marketers and designers. Saving Time, Saving Lives, Together.

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

OpenHealth Company is born of the conviction that data and the possibility of open analysis through new technologies represent a major challenge for the health sector: preserving healthcare systems subjected to increasing financial constraints, anticipating and managing health crises, improving the efficiency of healthcare policy, putting patients in charge of their care, making strategic choices in research fields... All these challenges imply well-considered implementation of healthcare data and that digital resources must play an ethical, effective and precise role. OpenHealth Company provides healthcare data analysis applied to marketing and clinical research for the healthcare product industry and will also focus on public health, epidemiological research and medico-economic issues for the entire healthcare world. OpenHealth Company is relaying on the historic expertise of Celtipharm in the collection and analysis of data concerning healthcare product consumption. OpenHealth Company brings together over 50 experts from the world of health studies, doctors, pharmacists, bio-statisticians, epidemiologists, data scientists, healthcare economists and digital healthcare specialists.

BIOSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France.